Experience

Prellis Biologics
• United States
• Biotechnology
• 1 - 100 Employee
• Chief Executive Officer

  • Aug 2022 - Present

Fulgent Getics
• Board Member

  • Jul 2022 - Present

Generate Biomedicines, Inc.
• United States
• Biotechnology Research
• 1 - 100 Employee
• Chief Scientific Officer

  • May 2021 - Aug 2022

Flagship Pioneering
• United States
• Biotechnology Research
• 300 - 400 Employee
• Operating Partner

  • Feb 2021 - May 2021


Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Vice President of Strategy, Commercialization & Innovation

  • Feb 2017 - Feb 2021

  In this role, I have five broad responsibilities. First, I lead our corporate strategy efforts. Second, I oversee our commercialization process (i.e., the process by which we develop new medicines and life cycle extensions). Third, I lead our efforts to manage our overall drug portfolio. Fourth, I lead the Innovation group that drives the digital health, artificial intelligence and data efforts at Amgen. Fifth, I directly supervise the leads of all of the drug programs in all stages of development (Global Program General Managers). They all report directly to me. I am a member of the Strategy Team (i.e., the Executive Committee) and report directly to the CEO Show less

• Vice President, Strategy and Innovation

  • Jan 2016 - Feb 2017

  In this role, I led the Amgen Digital health group responsible for all aspects of our digital strategies and execution, our therapy delivery innovation group responsible for drug device and delivery strategies and business development and the corporate strategy group. I was a member of the Strategy Team (i.e., the Executive Committee) and reported directly to the CEO.

• Vice President Strategy

  • Dec 2012 - Dec 2015

  Drove a transformation effort across the entire company including strategy, structure, processes and cost. Led a core group of 40 associates driving 28 major initiatives across all aspects of the company (e.g., redesign commercial model, change the development model, restructure research and translational medicine, reset the manufacturing network, launch digital health group, take significant costs our of G&A).



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Head of Molecular Diagnostics

  • Dec 2008 - Nov 2012

  Founded this new group starting from a zero base. As the general manager, I built and led a ~750-person team to drive personalized medicine solutions for Novartis. Responsible for delivering companion diagnostics for Novartis medicines and for building a molecular diagnostics business. At scale, it was a fully integrated global business unit (e.g., manufacturing, R&D, all G&A functions) with a >200M P&L.

• Head of Strategic Planning

  • Apr 2008 - Aug 2009

• Head of Strategic Planning, Pharma Division

  • Feb 2007 - Sep 2008


McKinsey & Company
• Business Consulting and Services
• 700 & Above Employee
• Partner

  • Jun 2000 - Jan 2007


Massachusetts Institute of Technology (MIT)

• Postdoctoral Fellow

  • Feb 1997 - Jun 2000

  My postdoctoral work was directed at protein structure function relationships and protein design using computational and combinatorial (bench) approaches. My postdoctoral work was directed at protein structure function relationships and protein design using computational and combinatorial (bench) approaches.